公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA取消

1,296 记录

产品持有公司班级有效性
HOMOCISTEÍNA IMMULITE 200010345160673SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
Hematek 300010345161950SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAI现有
Hematek Stain Pak10345161660SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAI现有
Herpes I & II IgG IMMULITE 200010345161020SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAIII22/12/2033
IGF CONTROL MODULE10345160858SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IGF-I IMMULITE 200010345160695SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IGFBP-3 IMMULITE 200010345160688SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL-10 CONTROL MODULE IMMULITE10345160938SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL-10 IMMULITE 200010345162516SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL-1B DILUENT IMMULITE10345160785SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAI现有
IL-1b IMMULITE 200010345162519SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL-2R IMMULITE 200010345160936SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL-6 IMMULITE 200010345161003SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL-8 DILUENT IMMULITE10345160889SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAI现有
IL-8 IMMULITE 200010345162517SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IL2R ( MONO / POLY ) DILUENT IMMULITE10345160759SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAI现有
IL6(MONO/POLY) DILUENT IMMULITE10345160738SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAI现有
IMMULITE 2000 Anti-CCP IgG10345161855SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IMMULITE 2000 CMV IgM10345161051SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAIV25/02/2034
IMMULITE 2000 ECP10345161851SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IMMULITE 2000 ESTRIOL LIVRE10345161756SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAIII13/10/2035
IMMULITE 2000 HBsAg10345161625SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAIV28/09/2034
IMMULITE 2000 IgG Alérgeno-Específica10345161857SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IMMULITE 2000 IgG4 Alérgeno-Específica10345161856SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAII现有
IMMULITE 2000 NT-proBNP10345161052SIEMENS HEALTHCARE DIAGNÓSTICOS LTDAIII24/10/2035

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家